Your browser doesn't support javascript.
loading
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies.
Van Blarcom, Thomas; Lindquist, Kevin; Melton, Zea; Cheung, Wai Ling; Wagstrom, Chris; McDonough, Dan; Valle Oseguera, Cendy; Ding, Sheng; Rossi, Andrea; Potluri, Shobha; Sundar, Purnima; Pitts, Steven; Sirota, Marina; Galindo Casas, Meri; Yan, Yu; Jones, Jeffrey; Roe-Zurz, Zygy; Srivatsa Srinivasan, Surabhi; Zhai, Wenwu; Pons, Jaume; Rajpal, Arvind; Chaparro-Riggers, Javier.
Afiliação
  • Van Blarcom T; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Lindquist K; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Melton Z; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Cheung WL; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Wagstrom C; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • McDonough D; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Valle Oseguera C; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Ding S; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Rossi A; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Potluri S; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Sundar P; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Pitts S; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Sirota M; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Galindo Casas M; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Yan Y; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Jones J; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Roe-Zurz Z; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Srivatsa Srinivasan S; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Zhai W; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Pons J; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Rajpal A; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
  • Chaparro-Riggers J; a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.
MAbs ; 10(2): 256-268, 2018.
Article em En | MEDLINE | ID: mdl-29227213
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Engenharia de Proteínas / Cadeias Leves de Imunoglobulina / Anticorpos Biespecíficos / Biblioteca de Peptídeos Limite: Animals / Humans Idioma: En Revista: MAbs Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Engenharia de Proteínas / Cadeias Leves de Imunoglobulina / Anticorpos Biespecíficos / Biblioteca de Peptídeos Limite: Animals / Humans Idioma: En Revista: MAbs Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos